Jipan Xie, MD, PhD

Articles by Jipan Xie, MD, PhD

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension

ByStephanie Chen, PhD,Elyse Swallow, MPP, MA,John Jarvis, BA,Erika Ohashi, BA,Caroline Kelley, BA,Jipan Xie, MD, PhD,Eric Wu, PhD

June 22nd 2016

A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.

Latest Updated Articles

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension
Published: June 22nd 2016 | Updated:

Jipan Xie, MD, PhD

Articles by Jipan Xie, MD, PhD

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension

Latest Updated Articles

Trending on Pharmacy Times

Understanding Second Primary Tumors in C-POST: Definitions, Incidence, and Clinical Implications of Cemiplimab

Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC

Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals